Standardized for diagnosing and monitoring diabetes, the ARCHITECT fully-automated whole-blood glycated hemoglobin (HbA1c) assay gives your laboratory elevated confidence in results, increased efficiency, and minimized tech hands-on time.
Diabetes has been called the 21st century’s major public health concern and represents a serious global epidemic.
The ARCHITECT Clinical Chemistry HbA1c assay is designed to have diagnostics and monitoring claims for diabetes mellitus on ARCHITECT c4000 and ARCHITECT c8000. The assay does not have significant interference from the common hemoglobin variants and is a fully automated whole blood application with no manual pretreatment steps.
Improved patient management process, enhanced confidence in patient results, and improved laboratory workflow efficiencies all make the ARCHITECT Clinical Chemistry HbA1c a high-quality diagnostic tool in diabetes diagnosis and management.
Diagnostics at Abbott offers a complete portfolio of integrated solutions including Core Laboratory, Molecular, Point of Care, Rapid Diagnostics and Transfusion Medicine.
Learning Guide
Build key laboratory competencies and explore topics from various disciplines with our learning guides.
Customer Portal
Receive exclusive benefits and resources when you register to access to the customer portal.
Contact Us
Abbott's Representatives are ready to offer support, gather feedback, and answer any questions.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
